Synopsis
0
CEP/COS
0
EU WC
0
VMF
0
FDF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CREAM;TOPICAL - 0.05% **Federal Regi...DOSAGE - CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 16908
DOSAGE - OINTMENT;TOPICAL - 0.05% **Federal R...DOSAGE - OINTMENT;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 16909
DOSAGE - SOLUTION;TOPICAL - 0.05%
USFDA APPLICATION NUMBER - 18849
DOSAGE - CREAM;TOPICAL - 0.05% **Federal Regi...DOSAGE - CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 19117
DOSAGE - CREAM;TOPICAL - 0.1%
USFDA APPLICATION NUMBER - 21758
Related Excipient Companies
Minakem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seqens
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Solubilizers
Thickeners and Stabilizers
Parenteral
Emulsifying Agents
Film Formers & Plasticizers
Controlled & Modified Release
Surfactant & Foaming Agents
Co-Processed Excipients
Coating Systems & Additives
Granulation
Lubricants & Glidants
API Stability Enhancers
Direct Compression
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Fluocinonide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluocinonide, including repackagers and relabelers. The FDA regulates Fluocinonide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluocinonide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fluocinonide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fluocinonide supplier is an individual or a company that provides Fluocinonide active pharmaceutical ingredient (API) or Fluocinonide finished formulations upon request. The Fluocinonide suppliers may include Fluocinonide API manufacturers, exporters, distributors and traders.
click here to find a list of Fluocinonide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fluocinonide DMF (Drug Master File) is a document detailing the whole manufacturing process of Fluocinonide active pharmaceutical ingredient (API) in detail. Different forms of Fluocinonide DMFs exist exist since differing nations have different regulations, such as Fluocinonide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fluocinonide DMF submitted to regulatory agencies in the US is known as a USDMF. Fluocinonide USDMF includes data on Fluocinonide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fluocinonide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fluocinonide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fluocinonide Drug Master File in Japan (Fluocinonide JDMF) empowers Fluocinonide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fluocinonide JDMF during the approval evaluation for pharmaceutical products. At the time of Fluocinonide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fluocinonide suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fluocinonide Drug Master File in Korea (Fluocinonide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fluocinonide. The MFDS reviews the Fluocinonide KDMF as part of the drug registration process and uses the information provided in the Fluocinonide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fluocinonide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fluocinonide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fluocinonide suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fluocinonide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fluocinonide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fluocinonide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fluocinonide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fluocinonide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fluocinonide suppliers with NDC on PharmaCompass.
Fluocinonide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fluocinonide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fluocinonide GMP manufacturer or Fluocinonide GMP API supplier for your needs.
A Fluocinonide CoA (Certificate of Analysis) is a formal document that attests to Fluocinonide's compliance with Fluocinonide specifications and serves as a tool for batch-level quality control.
Fluocinonide CoA mostly includes findings from lab analyses of a specific batch. For each Fluocinonide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fluocinonide may be tested according to a variety of international standards, such as European Pharmacopoeia (Fluocinonide EP), Fluocinonide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fluocinonide USP).
LOOKING FOR A SUPPLIER?
